Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40

Abstract

The goal of this study is to determine the prevalence of 23 common diseases in subjects with a chronic airway obstruction and in controls. All subjects with a known diagnosis by their general practitioner of asthma or chronic obstructive pulmonary disease (COPD), and who were 40 years and older were selected (n = 1145). Subjects who were willing to participate (n = 591) and who appeared to have an irreversible airway obstruction (n = 290) were included. To recruit controls, a random sample was taken of 676 individuals who were 40 years and older and who were not diagnosed as having asthma or COPD by their general practitioner. Of these 676 individuals 421 were willing to participate. The presence of diseases was determined by using a questionnaire. One hundred and ninety-four subjects (73%) and 229 controls (63%) were shown to be suffering from one or more (other) diseases. In both groups, locomotive diseases, high blood pressure, insomnia and heart disease were most common. Locomotive diseases, insomnia, sinusitis, migraine, depression, stomach or duodenal ulcers and cancer were significantly more common in the subject group than in the control group. For both clinical and research purposes, it is important to consider the presence of diseases in patients with a chronic airway obstruction.

Introduction

Comorbidity may frequently occur in patients with a chronic airway obstruction who are over 40 years old. While this group mainly consists of chronic obstructive pulmonary disease (COPD) patients, most will have a history of heavy smoking. Both smoking and older age are considered risk factors for the occurrence of diseases. In addition, a chronic airway obstruction may in itself be a risk factor for other diseases, as it may result in complications such as heart failure.

Determining the presence of a combination of diseases is important for the clinical practice. First, it influences the quality of life of the patient 1, 2, which results in an increased need for health care [3]. Second, diagnosis, treatment and prognosis will be influenced by the occurrence of diseases other than chronic airway obstructions.

Comorbidity is also an important methodological issue in clinical trials and in studies on health-related quality of life. Most of these studies exclude patients with comorbidities. If comorbidity is frequently seen in patients with a chronic airway obstruction, the external validity of these studies may to a large extent be limited. Furthermore, studies in which patients with comorbidity are included and compared with controls may encounter a confounding effect if the comorbidities turn out to be more common among the patient group than among the control group.

For both clinical and research purposes it is thus important to consider the presence of other diseases in patients suffering from a chronic airway obstruction. Nevertheless, it is unclear which diseases should be our main concern as there is only limited information on the frequency and kind of diseases in this patient group. Also, it is unclear which diseases are more common among patients with a chronic airway obstruction than among controls. Only a few diseases have thus far been described in the studies that we found 2, 4, 5, 6. Our study therefore determines the prevalence of 23 common diseases in patients with a chronic airway obstruction and in controls.